Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
NCT: NCT02276547 · COMPLETED
NCT IDNCT02276547
StatusCOMPLETED
Start Date2015-02-05
Completion2024-12-09
SponsorShockwave Medical, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.
Frequently Asked Questions
What is Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System?
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System is a clinical trial registered under NCT02276547. Current status: COMPLETED.
What is the status of NCT02276547?
The current status of NCT02276547 (Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System) is: COMPLETED.
When did Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System start?
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System started on 2015-02-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.